Related Experiment Videos
The Impact of Anticoagulant Choice on Rates of Manipulation Under Anesthesia, Hematoma Formation, and Venous
Brandon Crowley1, Miles Hollimon2, Theodore Joaquin2
1Orthopaedic Surgery Resident, MedStar Georgetown University Hospital, Washington, District of Columbia.
Background:
Anticoagulation after total knee arthroplasty (TKA) remains a balance between clot prevention and postoperative bleeding. This study aimed to analyze anticoagulant choice for deep vein thrombosis prophylaxis on rates of stiffness requiring manipulation under anesthesia (MUA) and hematoma formation after TKA.
Methods:
A large national database was queried for all primary TKAs. We included patients who filled a prescription for an anticoagulant within three days before or five days after surgery. We excluded those who filled prescriptions for multiple or no anticoagulants. Logistic regression was used to compare potent anticoagulants (warfarin, Xa inhibitors, and low molecular weight heparin (LMWH)) to our control group receiving aspirin. The primary outcomes of interest were MUA or hematoma formation within 90 days postoperatively. After applying the exclusion criteria, 462,869 patients were available to review. Of those, 148,159 (32.05%) received aspirin, followed by factor Xa inhibitors (123,909 [26.80%]), warfarin (96,338 [20.84%]), and LMWH (84,962 [18.38%]).
Results:
Using logistic regression analyses, patients receiving factor Xa inhibitors (odds ratio [OR] 1.38 [95% confidence interval (CI) 1.32 to 1.43]), indirect factor Xa inhibitors (OR 1.33, [95% CI 1.19 to 1.48]), warfarin (OR 1.29 [95% CI 1.23 to 1.35]), and LMWH (OR 1.26, [95% CI 1.20 to 1.32]) had higher rates of MUA than the aspirin cohort. Additionally, when compared to aspirin, those receiving LMWH (OR 1.69 [95% CI 1.46 to 1.96]), indirect factor Xa inhibitors (OR 1.62 [95% CI 1.13 to 2.26]), direct factor Xa inhibitors (OR 1.55 [95% CI 1.35 to 1.78]), and warfarin (OR 1.33 [95% CI 1.14 to 1.55]) were at a significantly higher risk of hematoma formation.
Conclusions:
The use of aspirin for deep vein thrombosis prophylaxis after TKA is associated with a significantly lower risk of undergoing MUA and hematoma formation, without increasing the clotting risk profile, than more potent anticoagulants.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:30Venous Thrombosis IV: Nursing Management
01:20Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...